pretickt

Is LDOS a good stock to buy?

Leidos Holdings, Inc. · end-of-day data as of Nov 13, 2026

Leidos
LDOS · $15.92B
$130.53-0.4%
Nov 13, 2026 · close
$120$140SepOctNov9:3016:003 months -8.7%Nov 13 · close
▲ 5
  • PT$171.91 +31.7%
  • P/E vs sector-60.3%
  • FCF yield+12.6%
  • News
  • MA20×50Golden 8d ago
Neutral
  • Earnings in95d
  • P/E11.7x
  • RSI46
  • Support-0.2%
  • Resistance+6.0%
  • Off 52w high-36.3%
  • Volume0.8x
  • Bollingerlower half
  • P/E vs own-9.7%
  • ConsensusHold · 17
  • Trendsideways
  • Sector→ -15.8%
  • 52w range$99–$205
  • ATR+3.7%
  • Off ATH-36.6%
  • MAs2 of 4
▼ 2
  • Insiders-$141K
  • MACD-1.07

Updates with the 15-min delayed price. Not a forecast or investment advice.

Is Leidos a good stock to buy?

Leidos is strong on 1 of the 5 questions about the business. The price is low: 11.7 times its earnings, below its 3-year median of 16.2 (Nov 13, 2026). pretickt does not say whether to buy or sell.

  1. Demand steady
  2. Advantage some edge
  3. Economics profitable
  4. Execution delivers
  5. Fragility some risks
  6. Price below its usual
DemandDo people want more of what it sells?steady

LDOS sales growth revenue growth

+6%a year, for the last 3 years

Leidos' sales grew 6% a year for 3 years, to $17.17B in fiscal 2025.

LDOS analysts' forecast revenue estimates

+5%the sales they expect next fiscal year, on the last

Analysts expect Leidos' sales to grow 5% to $18.12B in fiscal 2026 (10 analysts).

LDOS competitors

pretickt analysis+3%its sales in 12 months, on a year before

Leidos' sales grew 3% in the 12 months to Oct 2, 2026, faster than Gartner (0%), slower than FIS (+24%), CDW (+11%) and Jack Henry (+7%).

Advantage moatIs it hard to copy?some edge

LDOS return on capital ROIC

pretickt analysis40%earned before tax on the money invested in it

Leidos earned 40% before tax on the capital invested in it in the 12 months to Oct 2, 2026; CDW 21% and FIS 6%.

LDOS margin on each sale gross margin

17%left after making the product

Leidos kept 17% of each sale after making the product in the 12 months to Oct 2, 2026; its competitors' median is 40%.

EconomicsDoes it make good money?profitable

LDOS margin after costs profit margin

11%of sales left after running the business

Leidos' operating margin was 11% in the 12 months to Oct 2, 2026, against 8% in fiscal 2022.

LDOS cash generated free cash flow

$2.01Bcash left after investing, last 12 months

Leidos generated $2.01B of free cash flow in the 12 months to Oct 2, 2026, more than its reported profit.

LDOS profit per share

+20%in its last fiscal year

Leidos' earnings per share grew 20% in fiscal 2025, to $11.13.

ExecutionDoes it deliver what it promises?delivers

LDOS earnings vs estimates

8 of 8quarters above the analysts' estimate

Leidos beat the analysts' profit estimate in each of its last 8 quarters, the latest on Nov 3, 2026.

LDOS insider selling

-$3.18Msold, net, by its executives in 12 months

Leidos' executives and directors sold a net $3.18M of shares in the 12 months to Nov 13, 2026; none bought.

LDOS number of employees

-2%fewer people in a year

Leidos had 47,000 employees at the end of fiscal 2025, 2% fewer than a year before.

LDOS CEO pay

$14.74Mfor fiscal 2025, 69% of it in stock and options

Leidos paid its CEO $14.74M for fiscal 2025, 69% of it in stock and options.

Fragility risksCould something break it?some risks

LDOS financial health Altman Z-score

3.1Altman Z-score, safe above 3

Leidos' Altman Z-score is 3.1 (Nov 13, 2026), above 3, where the safe zone starts.

LDOS quality checks Piotroski score

5 of 9checks passed

Leidos passes 5 of the 9 Piotroski checks in the 12 months to Oct 2, 2026; it misses on return on assets, the current ratio, gross margin and sales for its assets.

LDOS biggest customers

87%of sales from its biggest customer

U.S. Government made 87% of Leidos' sales in fiscal 2025.

Price valuationIs the price reasonable?below its usual

LDOS price vs profit P/E ratio

11.7×a year's earnings

Leidos' P/E ratio is 11.7 (Nov 13, 2026), below its 3-year median of 16.2.

LDOS price vs competitors

pretickt analysis11.7×a year's earnings, against its competitors

Investors pay 11.7 times Leidos' earnings (Nov 13, 2026), more than for FIS (4.4), less than for Jack Henry (24.4), CDW (20.0) and Gartner (13.7).

LDOS analysts' target price target

+32%to their average target

Analysts' average price target for Leidos is $172, 32% above the Nov 13, 2026 close of $130.53.

LDOS analyst ratings, 90 days

pretickt analysis
  • JP Morgandowngrade
0 up, 1 downratings raised and cut

In the 90 days to Nov 13, 2026, JP Morgan downgraded Leidos.

LDOS growth priced in fair value

pretickt analysis-6%a year, for ten years, and still worth the price

At $130.53 a share, Leidos' free cash flow could shrink about 6% a year for ten years and still be worth the price (Nov 13, 2026).

What is Leidos' P/E ratio?

Leidos' P/E ratio is 11.7 (Nov 13, 2026), below its 3-year median of 16.2. Investors pay 11.7 times Leidos' earnings (Nov 13, 2026), more than for FIS (4.4), less than for Jack Henry (24.4), CDW (20.0) and Gartner (13.7).

Who are Leidos' biggest competitors?

pretickt compares Leidos with FIS, Jack Henry, Gartner and CDW. Leidos' sales grew 3% in the 12 months to Oct 2, 2026, faster than Gartner (0%), slower than FIS (+24%), CDW (+11%) and Jack Henry (+7%).

Is Leidos profitable?

Leidos' operating margin was 11% in the 12 months to Oct 2, 2026, against 8% in fiscal 2022. Leidos generated $2.01B of free cash flow in the 12 months to Oct 2, 2026, more than its reported profit.

Are insiders selling Leidos stock?

Leidos' executives and directors sold a net $3.18M of shares in the 12 months to Nov 13, 2026; none bought.

How many employees does Leidos have?

Leidos had 47,000 employees at the end of fiscal 2025, 2% fewer than a year before.

Who are Leidos' biggest customers?

U.S. Government made 87% of Leidos' sales in fiscal 2025.

From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.